Showing results (331-340 of 462) with videos related to

Sort By:
Pageof 47
The Journal of Allergy and Clinical Immunology|July 4, 2006
Activation of T cells by carbamazepine and carbamazepine metabolitesYing Wu, Joseph P Sanderson, John Farrell, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
Chemical Research in Toxicology|May 15, 2013
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosisRosalind E Jenkins, Fiazia S Yaseen, Manal M Monshi, et al.
The Journal of Investigative Dermatology|July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for PsoriasisAmy C Foulkes, David S Watson, Daniel F Carr, et al.
European Journal of Clinical Pharmacology|March 29, 2019
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvementJennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2015
Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease RecurrenceNitin Kumar, Fabio Miyajima, Miao He, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2016
Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatmentSteve Turner, Ben Francis, Susanne Vijverberg, et al.
The Journal of Infectious Diseases|May 2, 2009
In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East AfricaPhilip Sasi, Abdi Abdulrahaman, Leah Mwai, et al.
Human Molecular Genetics|May 6, 2015
Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centralityNasir Mirza, Richard Appleton, Sasha Burn, et al.
British Journal of Pharmacology|July 19, 2020
Safety perspectives on presently considered drugs for the treatment of COVID-19Sophie L Penman, Robyn T Kiy, Rebecca L Jensen, et al.
Pageof 47